These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29705884)

  • 1. Building predictive in vitro pulmonary toxicity assays using high-throughput imaging and artificial intelligence.
    Lee JJ; Miller JA; Basu S; Kee TV; Loo LH
    Arch Toxicol; 2018 Jun; 92(6):2055-2075. PubMed ID: 29705884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput imaging-based nephrotoxicity prediction for xenobiotics with diverse chemical structures.
    Su R; Xiong S; Zink D; Loo LH
    Arch Toxicol; 2016 Nov; 90(11):2793-2808. PubMed ID: 26612367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling.
    Nyffeler J; Willis C; Lougee R; Richard A; Paul-Friedman K; Harrill JA
    Toxicol Appl Pharmacol; 2020 Jan; 389():114876. PubMed ID: 31899216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the oxidative potential of nanoparticles by the cytochrome c assay: assay improvement and development of a high-throughput method to predict the toxicity of nanoparticles.
    Delaval M; Wohlleben W; Landsiedel R; Baeza-Squiban A; Boland S
    Arch Toxicol; 2017 Jan; 91(1):163-177. PubMed ID: 27060086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs.
    Tolosa L; Pinto S; Donato MT; Lahoz A; Castell JV; O'Connor JE; Gómez-Lechón MJ
    Toxicol Sci; 2012 May; 127(1):187-98. PubMed ID: 22331495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting direct hepatocyte toxicity in humans by combining high-throughput imaging of HepaRG cells and machine learning-based phenotypic profiling.
    Hussain F; Basu S; Heng JJH; Loo LH; Zink D
    Arch Toxicol; 2020 Aug; 94(8):2749-2767. PubMed ID: 32533217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study.
    Prieto P; Cole T; Curren R; Gibson RM; Liebsch M; Raabe H; Tuomainen AM; Whelan M; Kinsner-Ovaskainen A
    Regul Toxicol Pharmacol; 2013 Apr; 65(3):344-65. PubMed ID: 23246604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of neuroprogenitor cells to chemical-induced apoptosis using a multiplexed assay suitable for high-throughput screening.
    Druwe I; Freudenrich TM; Wallace K; Shafer TJ; Mundy WR
    Toxicology; 2015 Jul; 333():14-24. PubMed ID: 25841707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing.
    Wetmore BA; Allen B; Clewell HJ; Parker T; Wambaugh JF; Almond LM; Sochaski MA; Thomas RS
    Toxicol Sci; 2014 Nov; 142(1):210-24. PubMed ID: 25145659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols.
    Tornier C; Rosdy M; Maibach HI
    Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging.
    Harris G; Palosaari T; Magdolenova Z; Mennecozzi M; Gineste JM; Saavedra L; Milcamps A; Huk A; Collins AR; Dusinska M; Whelan M
    Nanotoxicology; 2015 May; 9 Suppl 1():87-94. PubMed ID: 23859183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in vitro high-content imaging assay for the prediction of drug-induced lung toxicity.
    Fitzpatrick PA; Johansson J; Maglennon G; Wallace I; Hendrickx R; Stamou M; Balogh Sivars K; Busch S; Johansson L; Van Zuydam N; Patten K; Åberg PM; Ollerstam A; Hornberg JJ
    Arch Toxicol; 2024 Sep; 98(9):2985-2998. PubMed ID: 38806719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
    Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
    Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyto-genotoxic effects of smoke from commercial filter and non-filter cigarettes on human bronchial and pulmonary cells.
    Cavallo D; Ursini CL; Fresegna AM; Maiello R; Ciervo A; Ferrante R; Buresti G; Iavicoli S
    Mutat Res; 2013 Jan; 750(1-2):1-11. PubMed ID: 23010388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenobiotic metabolism and disposition in human lung cell models: comparison with in vivo expression profiles.
    Courcot E; Leclerc J; Lafitte JJ; Mensier E; Jaillard S; Gosset P; Shirali P; Pottier N; Broly F; Lo-Guidice JM
    Drug Metab Dispos; 2012 Oct; 40(10):1953-65. PubMed ID: 22798553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput toxicity testing of chemicals and mixtures in organotypic multi-cellular cultures of primary human hepatic cells.
    Orbach SM; Ehrich MF; Rajagopalan P
    Toxicol In Vitro; 2018 Sep; 51():83-94. PubMed ID: 29751030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PC12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis.
    Radio NM; Freudenrich TM; Robinette BL; Crofton KM; Mundy WR
    Neurotoxicol Teratol; 2010; 32(1):25-35. PubMed ID: 19559085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.
    Rotroff DM; Wetmore BA; Dix DJ; Ferguson SS; Clewell HJ; Houck KA; Lecluyse EL; Andersen ME; Judson RS; Smith CM; Sochaski MA; Kavlock RJ; Boellmann F; Martin MT; Reif DM; Wambaugh JF; Thomas RS
    Toxicol Sci; 2010 Oct; 117(2):348-58. PubMed ID: 20639261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.